Lactose (India) Ltd Stock Analysis

BSE: 524202 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 06-Dec-2022 17:13
55.15 -2.25 (-3.92%)

DeciZen - Make an Informed Decision on Lactose India

M-Cap below 100cr DeciZen not available

Lactose India Price Chart

P/E Ratio (SA) :
24.42
Market Cap :
72.3 Cr.
52-wk low :
36.7
52-wk high :
96.4
Bole Toh?

1. Is Lactose (India) Ltd a good quality company?

Data is not available for this company.

2. Is Lactose (India) Ltd undervalued or overvalued?

The key valuation ratios of Lactose (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Lactose (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lactose (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lactose India:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 5.7%-2.5%5%9.5%9.9%3.8%6.2%5.5%1.7%7.2%-
Value Creation Index -0.6-1.2-0.7-0.3-0.3-0.7-0.6-0.6-0.9-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 46.622.223.734.535.731.140.640.13545.949
YoY Gr. Rt. %--52.3%6.5%45.4%3.5%-12.8%30.6%-1.4%-12.7%31.4%-
Adj EPS 1.1-1.90.52.52.9-1.30.60.1-2.21.82.4
YoY Gr. Rt. %--276.9%NA377.4%13.4%-146.3%NA-88.7%-3242.9%NA-
BVPS (₹) 18.918.618.922.527.631.133.633.730.231.231.3
Adj Net Profit 0.8-1.50.52.22.8-1.30.60.1-2.52.33
Cash Flow from Ops. 14.57.512.71.57.60.24.97.42.28.5-
Debt/CF from Ops. 0.63.13.125.34.6238.57.45.321.34.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -0.2%5.2%4.2%31.4%
Adj EPS 6%-8.7%43.2%NA
BVPS 5.82.5-2.43.5
Share Price 21.3% -19.2% 45.2% 44.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 5.9-10.32.912.311.8-4.61.90.2-7.36.27.5
Op. Profit Mgn % 6.25.321.630.431.918.123.723.217.826.726
Net Profit Mgn % 1.8-6.91.96.57.8-4.31.60.2-7.256
Debt to Equity 0.61.62.51.91.31.21.11.11.31.10.9
Working Cap Days 140278235187207211158177219199165
Cash Conv. Cycle 52348425768649112310077

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.50%

Net Profit is growing at healthy rate in last 3 years 43.18%

Sales growth is good in last 4 quarters at 23.68%

Sales growth has been subdued in last 3 years 4.20%

Debt to equity has increased versus last 3 years average to 1.06

Latest Financials - Lactose (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 2.4 -
TTM Sales (₹ Cr.) 49.3 -
BVPS (₹.) 31.3 -
Reserves (₹ Cr.) 27 -
P/BV 1.83 -
PE 24.42 -
From the Market
52 Week Low / High (₹) 36.70 / 96.35
All Time Low / High (₹) 0.25 / 190.05
Market Cap (₹ Cr.) 72.3
Equity (₹ Cr.) 12.6
Face Value (₹) 10
Industry PE 37.7

Management X-Ray of Lactose India :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *3.9460.6160.6147.1547.1547.1541.2139.130.520.52
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Lactose India

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Lactose (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Lactose India on 06-Dec-2022 17:13 is : 55.15.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Dec-2022 17:13 the market cap of Lactose India stood at ₹ 72.26.
The latest PE ratio of Lactose India as of 06-Dec-2022 17:13 is 24.42.
The latest PB ratio of Lactose India as of 06-Dec-2022 17:13 is 1.83
The 52-week high of Lactose India is ₹ 96.35 and the 52-week low is ₹ 36.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Lactose India is ₹ 49.30 ( Cr.) .

About Lactose (India) Ltd

Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its  plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up’ by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well.

For ten years now, Lactose (India) Limited has stood for perfection, quality, constant innovation and complete dedication to their clients. With up to date technology, the company is one of India's leading producers of Edible and Pharmaceutical grade Lactose. Apart from this, the company also manufactures Dairy Whitener, Dairy Calcium, Whey Powder, Casein, Caseinate, Butter and Ghee.

The company still boasts of being the first company to manufacture Lactose in the Asian subcontinent. The company has since grown to be a leading player in the Lactose market and continues to supply consistent quality Lactose to several global giants in the pharmaceutical world. It commands a 40% overall market share and this makes the company the leading Lactose supplier in the country.

With its unparalled infrastructure of requisite equipment and dedicated work force, Lactose (India) has a state of the art manufacturing facility for contract manufacturing of pharmaceutical products.The latest in its diverse interests is the manufacturing of pharmaceutical formulations for Aventis Pharma (earlier-Hoechst Marion Roussel), for the purpose of domestic use and export to Russia.

The state of art manufacturing facilities for the manufacture of pharmacuetical formulations is in compliance with all international standards.The plant is approved under WHO-cGMP guidelines and also holds TUV certificate as an ISO 9001 : 2000 company.The manufacturing facilities include wet granulation,Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments.The manufacturing facilities is well supported by its total in-house Quality Control set-up with latest Testing equipments and an upto date Microbiology Testing Laboratory. The facility is supported by an equally competent and FDA approved Manufacturing professionals.

Besides providing lactose for pharmaceutical giants, food,confectionary and dairy companies in India, the company's product also leaves Indian shores for the African continent, South East Asia, and some of its other neighbouring countries.

After achieving its ambitious goal of being the most successful and leading Lactose manufacturer and supplier in the country, the company is now venturing aggressively into exports of pharmaceuticals and related products.

Product range of the company includes:

  • Edible and Pharmaceutical grade Lactose
  • Dairy Whitener
  • Dairy Calcium
  • Whey Powder
  • Casein
  • Caseinate
  • Butter and Ghee.

Awards & Achievements:

  • TUV Certificate
  • An ISO 9001:2000 Certified company
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now